Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Following large-scale anti-Israel protests across Bangladesh, at least 72 individuals were arrested for vandalism and looting. Demonstrations, condemning Israel's actions in Gaza, turned violent ...